Neopharma, a premier pharmaceuticals manufacturing company based in Abu Dhabi, has notified that it has received clearance from the UAE Ministry of Health for its antiviral medication Oseltamivir BR Flu.

It should be noted that the ministry's approval for Neopharma's drug comes at a time when the entire region is gripped by fears over the H1N1 pandemic. 

The company claims that drug is a preferred option to prevent and treat H1N1 flu in the region. 

Neopharma manufactures a wide range of products including antibiotics, analgesics, respiratory medicines, antihistamines, as well as medications for cardiovascular conditions and diabetes.